Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-07T13:48:13.006Z Has data issue: false hasContentIssue false

Modulation of murine intestinal immunity by Moringa oleifera extract in experimental hymenolepiasis nana

Published online by Cambridge University Press:  06 April 2017

M. Abdel-Latif*
Affiliation:
Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
G. El-Shahawi
Affiliation:
Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
S.M. Aboelhadid
Affiliation:
Department of Veterinary Parasitology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt
H. Abdel-Tawab
Affiliation:
Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
Rights & Permissions [Opens in a new window]

Abstract

The potential therapeutic value of Moringa oleifera extract (MOE), due to its anti-inflammatory and anti-oxidant effects, has been reported previously. In this study, Hymenolepis nana antigen (HNA) in combination with MOE was used in immunization against H. nana infection. Adult worm and egg counts were taken, while histological changes in the intestine were observed. Mucosal mast (MMCs) and goblet cells (GCs) were stained with specific stains, while serum and intestinal IgA were assayed using enzyme-linked immunosorbent assay (ELISA). Reduced glutathione (GSH) and lipid peroxidation (thiobarbituric acid reactive substances, TBARS) were assayed. Real-time polymerase chain reaction (PCR) was used for detection of mRNA expression in ileum tissue. The results demonstrated an improvement in the architecture of intestinal villi, decreased inducible nitric oxide synthase (iNOs) and TBARS, and increased GSH in HNA, MOE and MOE + HNA groups. In the same groups, an increase in GCs, mucin 2 (MUC2), interleukins (IL)-4, -5 and -9, and stem cell factor (SCF) versus a decrease in both interferon-gamma (IFN-γ) and transforming growth factor (TGF-β) expression appeared. HNA and MOE + HNA increased serum and intestinal IgA, respectively. MOE decreased MMCs and achieved the highest reductions in both adult worms and eggs. In conclusion, MOE could achieve protection against H. nana infections through decreased TGF-β, IFN-γ and MMC counts versus increased GC counts, T-helper cell type 2 (Th2) cytokines and IgA level.

Information

Type
Research Papers
Copyright
Copyright © Cambridge University Press 2017 
Figure 0

Table 1. Primer sequences of detected mouse genes in RT-PCR.

Figure 1

Table 2. Means, statistical significance and reduction percentages of both worm and egg counts after HNA, MOE or MOE+ HNA treatments.

Figure 2

Fig. 1. Effect of HNA, MOE or MOE + HNA on intestinal histological structures in experimental hymenolepiasis nana. The figure shows damage in intestinal villi in the infected group (b) compared to non-infected group (a). Pre-treatments with MOE (d) or MOE + HNA (e) were better than HNA alone (c), and could reverse the intestinal changes. dv, Degenerated or disrupted villi; td, tissue debris; lin, leucocyte infiltration; gc, goblet cell. Scale bar: 100 μm.

Figure 3

Fig. 2. Effect of HNA, MOE or MOE + HNA on intestinal mast cell infiltration. Mast cells were stained with naphthol AS-D chloroacetate and appeared at the base of villi (a and b). (c) Mean number of mast cells per 10 villi ± SD in MOE + HNA versus HNA, or MOE versus infected groups, showed significant decreases (*, P < 0.05). Scale bars in (a) and (b): 50 and 20 μm, respectively.

Figure 4

Fig. 3. Effect of HNA, MOE or MOE + HNA on GC hypoplasia (P < 0.01; c) and decreased mRNA expression of MUC2 (P < 0.001; d) in infected versus non-infected groups. Mean number of (a) AB or (b) PAS-stained GCs per 10 villi ± SD in MOE and MOE + HNA groups increased significantly (P < 0.05 and P < 0.001, respectively) in comparison with the infected group (c). MUC2 expression increased significantly (P < 0.001) in all treated groups in comparison with the infected group. gc, Goblet cell. # and * represent statistical P values for infected versus non-infected, and treated versus infected groups, respectively. Scale bar: 50 μm.

Figure 5

Fig. 4. Effect of HNA, MOE or MOE + HNA on GSH (a), TBARS (b) and iNOs mRNA (c) levels in intestinal tissue. Compared to the non-infected group, GSH decreased (P < 0.001) while TBARS and iNOs increased (P < 0.001) in the infected group. Compared to the infected group, GSH increased (P < 0.001), while TBARS and iNOs decreased (P < 0.001) in treatment groups. # and * represent statistical P values for infected versus non-infected, and treated versus infected groups, respectively.

Figure 6

Fig. 5. Effect of HNA, MOE or MOE+ HNA on IgA levels in serum and intestinal washes. The figure shows non-significant changes in the serum and intestinal wash samples of the infected group versus the non-infected group. Compared to the infected group, HNA increased serum (P < 0.001) but not intestinal IgA. MOE and MOE + HNA increased serum (P < 0.05 and P < 0.01, respectively) and intestinal (P < 0.01 and P < 0.001, respectively) IgA. * and # represent statistical P values for treated versus infected groups, or MOE + HNA versus HNA, respectively.

Figure 7

Fig. 6. Effect of HNA, MOE or MOE + HNA on intestinal mRNA expression of IL-4, IL-5, IL-9, IFN-γ, SCF and TGF-β. Compared to the non-infected group, the infected group showed a decrease (P < 0.001) in IL-4, -5, -9 and SCF expression and an increase (P < 0.001) in IFN-γ and TGF-β. In relation to the infected group, treated groups indicated significant increases in IL-4, -5, -9 and SCF, and decreases in IFN-γ and TGF-β. # and * represent statistical P values for infected versus non-infected, and treated versus infected groups, respectively.